GlassScriptPhysician profile
Robert Sealand
NPI 1093976227
$3,716.41
in general payments reported to CMS, 2019-2025
40 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $998 · 2020: $41.49 · 2021: $199 · 2022: $1,150 · 2023: $718 · 2024: $456 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,328.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $458.07 | 2019-2023 | Jardiance, Lyumjev, Mounjaro |
| Abbott Laboratories | $437.74 | 2019-2025 | Freestyle Libre 3 |
| Insulet Corporation | $392.94 | 2019-2024 | Omnipod |
| Novo Nordisk INC | $250.87 | 2019-2023 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $228.50 | 2019-2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $228.40 | 2019-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $195.20 | 2019-2023 | |
| Corcept Therapeutics | $113.33 | 2019-2023 | Korlym |
| Xeris Pharmaceuticals, INC. | $104.97 | 2022-2023 | Gvoke Hypopen |
| Antares Pharma, INC. | $100.83 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $87.18 | 2019-2023 | Unithroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.16 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.71 | 2022 | |
| Pfizer INC. | $72.24 | 2019-2023 | |
| Beta Bionics, INC. | $61.37 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifescan, INC. | $51.40 | 2021-2022 | |
| Amgen INC. | $51.07 | 2019-2022 | |
| Horizon Therapeutics Plc | $50.39 | 2022 | |
| Tandem Diabetes Care, INC. | $48.99 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $48.56 | 2022-2023 | Minimed 780g |
| Shire North American Group INC | $46.79 | 2019 | |
| Cequr Corporation | $44.71 | 2023-2025 | Cequr Simplicity |
| Recordati_rare_diseases_inc. | $44.30 | 2023 | Signifor Lar, Isturisa |
| Embecta Corp. | $40.77 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Valeritas, INC. | $35.36 | 2019 | |
| Merck Sharp & Dohme LLC | $35.25 | 2019 | |
| Ibsa Pharma INC. | $34.85 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $32.25 | 2023 | Evkeeza |
| Sequel Med Tech, LLC | $28.89 | 2025 | Twiist |
| Janssen Pharmaceuticals, INC | $28.72 | 2019 | |
| Radius Health, INC. | $27.73 | 2019 | |
| Becton, Dickinson and Company | $24.20 | 2019 | |
| Eisai INC. | $23.25 | 2022 | |
| Abbvie INC. | $23.01 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.08 | 2022 | |
| Halozyme INC | $17.11 | 2023 | |
| Medtronic Minimed, INC. | $15.72 | 2019 | |
| Esperion Therapeutics, INC. | $15.64 | 2021 | |
| Amarin Pharma, INC. | $15.26 | 2019 | |
| Aytu Biopharma, INC. | $14.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sealand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.